Open Site Navigation

In-Person Only

End users who will benefit from attending include CXOs, EVPs, SVPs, VPs, Executive Directors, Directors and Global Heads responsible for:

Invited Audience

  • Tissue Engineering

  • Cell and Gene Manufacturing

  • Gene Therapy | Cell Therapy

  • Biomedical Engineering

  • Cell Line Development

  • Bioprocess Development

Quality Over Quantity

  • Technical Operations and Manufacturing

  • Investigational Material Supply Chain

  • Product Research and Development

  • Blockchain

Cohesive Networking

  • Regulatory Affairs

  • Regenerative Medicine

  • Cell Engineering

  • Immune Deficiencies

  • Stem Cell Manufacturing

  • ​Novel Vector Systems

Speakers 30%
End Users 60%
Buying power 90%
Vendors 10%

Industrialisation & Commercialisation For Cell & Gene Therapy, Manufacturing & Supply

Learn more

Event details

Learn more

Register now

Learn more


"The Global Cell and Gene Therapy Market is estimated to be up to $67 Billion by 2030."

The 6th Annual Cell and Gene Therapy Innovation Summit is an exclusive in-person-only gathering for up to 200 decision-makers, intellectual vanguards and captains of industry.

With more regenerative medicine products approaching clinical testing and commercialisation, seize this opportunity to hear detailed insights and industry best practices from renowned presenters.

#CGTI 2023 programme will highlight the manufacturing challenges facing Cell & Gene Therapy, bringing clear insights and industry best practices from industry leaders.

Achieve a deeper understanding of the many manufacturing and industrialisation burdens unique to carrying durable and curative therapies to needy patients.

The 6th Annual Cell And Gene Innovation Summit

15th - 16th February 2023 - Hotel Palace Berlin 5*

08:45 am

The Agenda




Key Speakers